The Centers for Medicare and Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of ...

The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

Despite pledges to lower drug costs through Trump-backed pricing deals and direct-to-patient programs, pharmaceutical ...